Literature DB >> 8645742

Storage of noncryopreserved periphered blood stem cells for transplantation.

G Hechler1, R Weide, J Heymanns, H Köppler, K Havemann.   

Abstract

Mobilized peripheral blood stem cells (PBSC) were collected in autologous plasma and acid-citrate-dextrose formula A (ACD-A) by leukaphereses using the CS3000 cell separator (Baxter) and stored at 4 degrees C in a refrigerator for 8 days. We have looked at the viability of the nucleated cells with the trypan blue test and the proliferation and differentiation capacity using a standardized progenitor cell cloning assay. The changes in viability, granulocyte-macrophage colony-forming units (CFU-GM), erythroid burst-forming units (BFU-E), and mixed-lineage colony-forming units (CFU-GEMM) were determined daily during the storage period. Viability was 90.8% (SD 8%) at day 0 and declined to a mean of 69.5% (SD 15.5%) at day 8. CFU-GM decreased to 47% (SD 28.7%), CFU-GEMM to 48% (SD 42.2%), and BFU-E to 40.1% (SD 18.4%) after 6 days. After 5 days of storage the mean viability was 79.7% (SD 17.8%), whereas the mean CFU-GM were 65.3% (SD 28.4%) the mean CFU-GEMM were 61.8% (SD 30.4%) and the mean BFU-E were 55.1% (SD 18.2%). At day 4 viability was still 82.5% (SD 17.0%), recovery of CFU-GM was 78.5% (SD 28.8%), recovery of CFU-GEMM was 70.7% (SD 40.4%) and recovery of BFU-E was 65.0% (SD 17.5%). These data show, that PBSC can be stored safely over at least 5 days at 4 degrees C while the patient receives high-dose chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645742     DOI: 10.1007/s002770050176

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Collection, processing and storage of peripheral blood stem cells (PBSC).

Authors:  S Magrin; S Gentile; A Santoro; A Indovina; R Scimè; D Hauser; R Felice; F Raiata; F Fabbiano; I Majolino
Journal:  Haematologica       Date:  1991-03       Impact factor: 9.941

2.  Peripheral blood-derived stem cells can be successfully cryopreserved without using controlled-rate freezing.

Authors:  J Jackson; T Kloster; L Welniak; M Damon; B Rehder; B Schmechel; B Ward; A Kessinger
Journal:  Prog Clin Biol Res       Date:  1992

3.  [Collection and transplantation of hematopoietic stem cells of circulating blood].

Authors:  M Körbling; D Fehrentz; K Rother; W Hunstein
Journal:  Beitr Infusionsther       Date:  1988

4.  Liquid storage of unseparated human bone marrow. Evaluation of hematopoietic progenitors by clonal assay.

Authors:  L C Lasky; J McCullough; E D Zanjani
Journal:  Transfusion       Date:  1986 Jul-Aug       Impact factor: 3.157

5.  Liquid storage of bone marrow.

Authors:  A Mangalik; W A Robinson; C Drebing; D Hartmann; J H Joshi
Journal:  Exp Hematol       Date:  1979       Impact factor: 3.084

6.  Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest.

Authors:  R Haas; S Hohaus; G Egerer; R Ehrhardt; B Witt; W Hunstein
Journal:  Bone Marrow Transplant       Date:  1992-06       Impact factor: 5.483

7.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.

Authors:  L B To; M M Roberts; D N Haylock; P G Dyson; A L Branford; D Thorp; J Q Ho; G W Dart; N Horvath; M L Davy
Journal:  Bone Marrow Transplant       Date:  1992-04       Impact factor: 5.483

8.  Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting.

Authors:  T Teshima; M Harada; Y Takamatsu; K Makino; S Taniguchi; S Inaba; S Kondo; T Tanaka; K Akashi; I Minamishima
Journal:  Bone Marrow Transplant       Date:  1992-09       Impact factor: 5.483

9.  Increase in circulating stem cells following chemotherapy in man.

Authors:  C M Richman; R S Weiner; R A Yankee
Journal:  Blood       Date:  1976-06       Impact factor: 22.113

10.  Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF.

Authors:  F Ravagnani; S Siena; M Bregni; G Sciorelli; A M Gianni; G Pellegris
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

View more
  3 in total

Review 1.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

2.  Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation.

Authors:  Khalid Ahmed Al-Anazi
Journal:  Bone Marrow Res       Date:  2012-05-28

3.  Outcomes of Non-Cryopreserved Versus Cryopreserved Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Multiple Myeloma.

Authors:  Pokpong Piriyakhuntorn; Adisak Tantiworawit; Thanawat Rattanathammethee; Sasinee Hantrakool; Chatree Chai-Adisaksopha; Ekarat Rattarittamrong; Lalita Norasetthada
Journal:  Ann Transplant       Date:  2020-12-11       Impact factor: 1.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.